Delfi Diagnostics

About:

Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.

Website: https://delfidiagnostics.com

Top Investors: Eli Lilly, Menlo Ventures, T. Rowe Price, OrbiMed, Foresite Capital

Description:

Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.

Total Funding Amount:

$331M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)delfidiagnostics.com

Founders:

Alessandro Leal, Victor Velculescu

Number of Employees:

101-250